作者：
Georgina S F,Anderson [1]
;
Jose,Ballester-Beltran [2]
;
George,Giotopoulos [2]
;
Jose A,Guerrero [2]
;
Sylvanie,Surget [3]
;
James C,Williamson [1]
;
Tsz,So [2]
;
David,Bloxham [4]
;
Anna,Aubareda [1]
;
Ryan,Asby [5]
;
Ieuan,Walker [1]
;
Lesley,Jenkinson [2]
;
Elizabeth J,Soilleux [2]
;
James P,Roy [3]
;
Ana,Teodósio [1]
;
Catherine,Ficken [5]
;
Leah,Officer-Jones [6]
;
Sara,Nasser [7]
;
Sheri,Skerget [1]
;
Jonathan J,Keats [1]
;
Peter,Greaves [1]
;
Yu-Tzu,Tai [1]
;
Kenneth C,Anderson [8]
;
Marion,MacFarlane [8]
;
James E,Thaventhiran [8]
;
Brian J P,Huntly [9]
;
Paul J,Lehner [10]
;
Michael A,Chapman [10]
作者单位：
MRC Toxicology Unit and.
[1]
Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
[2]
Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.
[3]
Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
[4]
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
[5]
CRUK-AstraZeneca Antibody Alliance Laboratory, Cambridge, United Kingdom.
[6]
Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
[7]
Translational Genomics Research Institute, Phoenix, AZ.
[8]
Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.
[9]
Dana Farber Cancer Institute, Boston, MA; and.
[10]
Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom.
[11]
DOI
10.1182/blood.2021015161
PMID
35134130
发布时间
2024-04-26
换一批
换一批
